AMIX logo

Autonomix Medical (AMIX) Financials

Balance sheets

Dec 1, 2024Sep 1, 2024Jun 1, 2024Mar 1, 2024Dec 1, 2023Sep 1, 2023Jun 1, 2023Mar 1, 2023Dec 1, 2022

Total Assets

$12.0 M(+122.5%)$5.4 M(-24.3%)$7.1 M(-24.6%)$9.4 M(+420.0%)$1.8 M--$865.0 K-

Current Assets

$11.9 M(+122.9%)$5.4 M(-24.3%)$7.1 M(-24.6%)$9.4 M(+457.3%)$1.7 M--$865.0 K-

Non Current Assets

$20.0 K(+17.6%)$17.0 K(-10.5%)$19.0 K(+18.8%)$16.0 K(-87.1%)$124.0 K--$0.0-

Total Liabilities

$2.2 M(-4.2%)$2.3 M(+29.7%)$1.8 M(+1.5%)$1.8 M(-76.0%)$7.4 M--$221.0 K-

Current Liabilities

$2.2 M(+78.6%)$1.3 M(+64.7%)$763.0 K(-1.8%)$777.0 K(-20.1%)$973.0 K--$221.0 K-

Long Term Liabilities

$0.0(-100.0%)$1.1 M(+4.1%)$1.0 M(+4.1%)$1.0 M(-84.4%)$6.4 M--$0.0-

Shareholders Equity

$9.7 M(+220.6%)$3.0 M(-42.8%)$5.3 M(-30.7%)$7.6 M(+236.3%)-$5.6 M--$644.0 K-

Book Value

$9.7 M(+220.6%)$3.0 M(-42.8%)$5.3 M(-30.7%)$7.6 M(+236.3%)-$5.6 M--$644.0 K-

Working Capital

$9.7 M(+136.4%)$4.1 M(-35.1%)$6.3 M(-26.7%)$8.6 M(+1109.8%)$712.0 K--$644.0 K-

Cash And Cash Equivalents

$11.8 M(+129.3%)$5.2 M(-23.6%)$6.8 M(-21.6%)$8.6 M(+606.7%)$1.2 M--$865.0 K-

Accounts Payable

$232.0 K(-59.6%)$574.0 K(+100.0%)$287.0 K(-41.7%)$492.0 K(-25.8%)$663.0 K--$173.0 K-

Accounts Receivable

---------

Short Term Debt

$1.1 M--------

Long Term Debt

-$1.1 M(+4.1%)$1.0 M(+4.1%)$1.0 M(-31.2%)$1.5 M----

Total Debt

$1.1 M(+4.2%)$1.1 M(+4.1%)$1.0 M(+4.1%)$1.0 M(-31.2%)$1.5 M(+100.0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0

Debt To Equity

0.1(-66.7%)0.4(+80.0%)0.2(+53.9%)0.1(+150.0%)-0.3--0.0-

Current Ratio

5.3(+24.6%)4.3(-54.0%)9.3(-23.3%)12.1(+598.8%)1.7--3.9-

Quick Ratio

---------

Inventory

---------

Retained Earnings

-$47.2 M(-6.1%)-$44.5 M(-6.7%)-$41.7 M(-6.9%)-$39.0 M(-16.1%)-$33.6 M---$23.5 M-

PB Ratio

0.9(-82.2%)5.1(-37.2%)8.1(-17.1%)9.8-----

Income statements

Dec 1, 2024Sep 1, 2024Jun 1, 2024Mar 1, 2024Dec 1, 2023Sep 1, 2023Jun 1, 2023Mar 1, 2023Dec 1, 2022

EPS

-$1.5(+40.9%)-$2.5(+11.8%)-$2.8(+51.2%)-$5.7(-94.7%)-$2.9(+48.5%)-$5.7(-598.3%)-$0.8(-31.7%)-$0.6(-20.8%)-$0.5

TTM EPS

-$12.5(+10.7%)-$14.0(+18.9%)-$17.2(-13.0%)-$15.2(-50.6%)-$10.1(-31.7%)-$7.7(-292.4%)-$2.0(-72.0%)-$1.1(-120.8%)-$0.5

Revenue

---------

TTM Revenue

---------

Total Expenses

$2.7 M(-3.1%)$2.8 M(+3.0%)$2.8 M(+13.9%)$2.4 M(-17.4%)$2.9 M(+131.3%)$1.3 M(+45.1%)$871.0 K(+32.6%)$657.0 K(+20.8%)$544.0 K

Operating Expenses

$2.7 M(-3.1%)$2.8 M(+3.0%)$2.8 M(+13.9%)$2.4 M(-17.4%)$2.9 M(+131.3%)$1.3 M(+45.1%)$871.0 K(+32.6%)$657.0 K(+20.8%)$544.0 K

Cost Of Goods Sold

---------

TTM Cost Of Goods Sold

---------

Gross Profit

---------

TTM Gross Profit

---------

Gross Margin

---------

Operating Profit

-$2.7 M(+3.1%)-$2.8 M(-3.0%)-$2.8 M(-13.9%)-$2.4 M(+17.4%)-$2.9 M(-131.3%)-$1.3 M(-45.1%)-$871.0 K(-32.6%)-$657.0 K(-20.8%)-$544.0 K

TTM Operating Profit

-$10.8 M(+1.6%)-$10.9 M(-16.8%)-$9.4 M(-25.2%)-$7.5 M(-30.8%)-$5.7 M(-71.3%)-$3.3 M(-61.0%)-$2.1 M(-72.5%)-$1.2 M(-120.8%)-$544.0 K

Operating Margin

---------

Net Income

-$2.7 M(+3.4%)-$2.8 M(-4.0%)-$2.7 M(+50.1%)-$5.4 M(-73.7%)-$3.1 M(+48.5%)-$6.0 M(-598.3%)-$865.0 K(-31.7%)-$657.0 K(-20.8%)-$544.0 K

TTM Net Income

-$13.6 M(+2.9%)-$14.0 M(+18.7%)-$17.3 M(-11.9%)-$15.4 M(-44.5%)-$10.7 M(-31.7%)-$8.1 M(-292.4%)-$2.1 M(-72.0%)-$1.2 M(-120.8%)-$544.0 K

Net Margin

---------

EBIT

-$2.7 M(+3.5%)-$2.8 M(-4.0%)-$2.7 M(+50.4%)-$5.4 M(-74.1%)-$3.1 M(+49.0%)-$6.0 M(-598.3%)-$865.0 K(-31.7%)-$657.0 K(-20.8%)-$544.0 K

TTM EBIT

-$13.5 M(+3.0%)-$13.9 M(+19.1%)-$17.1 M(-11.7%)-$15.3 M(-44.2%)-$10.6 M(-31.3%)-$8.1 M(-292.4%)-$2.1 M(-72.0%)-$1.2 M(-120.8%)-$544.0 K

EBITDA

-$2.6 M(+3.6%)-$2.7 M(-4.0%)-$2.6 M(+50.8%)-$5.3 M(-74.6%)-$3.0 M(+49.6%)-$6.0 M(-598.3%)-$865.0 K(-31.7%)-$657.0 K(-20.8%)-$544.0 K

TTM EBITDA

-$13.3 M(+3.1%)-$13.7 M(+19.5%)-$17.0 M(-11.5%)-$15.3 M(-43.9%)-$10.6 M(-30.9%)-$8.1 M(-292.4%)-$2.1 M(-72.0%)-$1.2 M(-120.8%)-$544.0 K

Selling, General & Administrative Expenses

$1.7 M(+2.5%)$1.7 M(-7.6%)$1.8 M(+4.7%)$1.7 M(-23.2%)$2.2 M(+182.1%)$793.0 K(+57.6%)$503.0 K(+101.2%)$250.0 K(-27.5%)$345.0 K

TTM SGA

$6.9 M(-7.2%)$7.4 M(+13.3%)$6.5 M(+24.7%)$5.3 M(+38.8%)$3.8 M(+100.0%)$1.9 M(+72.2%)$1.1 M(+84.5%)$595.0 K(+72.5%)$345.0 K

Depreciation And Amortization

$47.0 K(+4.4%)$45.0 K(+4.7%)$43.0 K(-6.5%)$46.0 K(+31.4%)$35.0 K(+100.0%)$0.0(0%)$0.0-$0.0

TTM D&A

$181.0 K(+7.1%)$169.0 K(+36.3%)$124.0 K(+53.1%)$81.0 K(+131.4%)$35.0 K(+100.0%)$0.0(0%)$0.0-$0.0

Interest Expense

$45.0 K(+4.7%)$43.0 K(+4.9%)$41.0 K(-10.9%)$46.0 K(+39.4%)$33.0 K(+100.0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0

TTM Interest Expense

$175.0 K(+7.4%)$163.0 K(+35.8%)$120.0 K(+51.9%)$79.0 K(+139.4%)$33.0 K(+100.0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0

Income Tax

$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0

TTM Income Tax

$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0

PE Ratio

---------

PS Ratio

---------

Cashflow statements

Dec 1, 2024Sep 1, 2024Jun 1, 2024Mar 1, 2024Dec 1, 2023Sep 1, 2023Jun 1, 2023Mar 1, 2023Dec 1, 2022

Cash From Operations

-$2.3 M(-44.2%)-$1.6 M(+13.8%)-$1.9 M(+19.0%)-$2.3 M(+10.5%)-$2.6 M(-123.4%)-$1.1 M(-73.1%)-$661.0 K--$1.2 M

TTM CFO

-$8.0 M(+3.1%)-$8.3 M(-5.8%)-$7.8 M(-17.9%)-$6.6 M(-52.4%)-$4.4 M(-43.5%)-$3.0 M(-60.4%)-$1.9 M--$1.2 M

Cash From Investing

-$5000.0(-100.0%)$0.0(+100.0%)-$5000.0(-66.7%)-$3000.0(+81.3%)-$16.0 K(-100.0%)$0.0(0%)$0.0-$0.0

TTM CFI

-$13.0 K(+45.8%)-$24.0 K(0%)-$24.0 K(-26.3%)-$19.0 K(-18.8%)-$16.0 K(-100.0%)$0.0(0%)$0.0-$0.0

Cash From Financing

$9.0 M(+100.0%)$0.0(0%)$0.0(-100.0%)$9.7 M(+488.4%)$1.6 M(+370.0%)$350.0 K(-87.2%)$2.7 M-$0.0

TTM CFF

$18.7 M(+64.7%)$11.3 M(-3.0%)$11.7 M(-19.0%)$14.4 M(+204.7%)$4.7 M(+53.3%)$3.1 M(+12.8%)$2.7 M-$0.0

Free Cash Flow

-$2.3 M(-44.5%)-$1.6 M(+14.1%)-$1.9 M(+18.9%)-$2.3 M(+11.0%)-$2.6 M(-124.8%)-$1.1 M(-73.1%)-$661.0 K--$1.2 M

TTM FCF

-$8.0 M(+3.2%)-$8.3 M(-5.8%)-$7.9 M(-17.9%)-$6.7 M(-52.3%)-$4.4 M(-44.0%)-$3.0 M(-60.4%)-$1.9 M--$1.2 M

CAPEX

---------

TTM CAPEX

---------

Dividends Paid

---------

TTM Dividends Paid

---------

TTM Dividend Per Share

---------

TTM Dividend Yield

---------

Payout Ratio

---------